The big ones
SoftBank, SoftBank, SoftBank. It feels like that’s all we’re talking about on this podcast, and that shows no sign of stopping, as the telecoms and internet group has taken the wrapper off a $5bn vehicle dubbed SoftBank Innovation Fund which will focus on Latin American deals.
After all these years, ride hailing still looks to be the area of the VC world where the big bucks are going, and Grab has boosted its series H round to $4.5bn with a $1.46bn investment by SoftBank Vision Fund.
Lyft has become the first of the ride hailing companies to file for an IPO, setting an initial target of $100m. Rakuten is the largest investor in Lyft, valued at some $15bn last year, while Alphabet and GM also own decent-sized stakes, but the greatest attention may be paid to its finances.
Beam Therapeutics, a genetic medicine developer spun out of Harvard University, has followed up an $87m series A round in mid-2018 with a $135m series B featuring GV that will go to recruitment, technology development and the expansion of its base editing programs.
Go-Jek is meanwhile said to be valued at about $9.5bn, and has raised $100m from conglomerate Astra International as part of a round it intends to close at around $3bn.
Chinese smart electric vehicle producer WM Motor has raised $446m in a series C round led by existing investor Baidu, with which WM is also partnering in order to further develop its AI technology in a bid to bring self-driving vehicles to market in the next three years.
Vision Fund, which really is having an insanely busy month even by its own high standards, has also invested $350m to lead a $395m series F round for last-mile logistics provider Delhivery.
Mobile bank Chime has also reached unicorn status, tripling its valuation to $1.5bn with a $200m series D round led by DST Global.
Digital insurance startup Friday has received $128m in funding on, suitably enough, the Friday before last, with the majority of the cash coming from insurance holding company Baloise Group, which founded the company at the start of 2017 and which remains its majority shareholder.
SoftBank Vision Fund has been the biggest growth-stage investor of the past two years and if anything its activity is ramping up, the unit having made nine or 10-digit investments in Nuro, Chehaoduo, Flexport, DoorDash and Clutter in the past month.
Healthcare investment firm Gilde Healthcare has had a long-term partnership with Philips, which has backed several of its funds, while Johnson & Johnson has also been a corporate LP for the firm.
Contrary Capital, a university-focused venture firm with connections to dozens of US institutions, aims to raise $35m for its second vehicle from pooled investment funds, according to a regulatory filing published Wednesday.
Biogen has offered to pay $25.50 in cash per share to pay a total of approximately $800m for Nightstar Therapeutics, a spinout of University of Oxford that went public back in 2017.
Social media company YY owned almost 32% of livestreaming platform developer Bigo after leading its $272m series D round last June, and now it’s paid $1.45bn to complete the acquisition by purchasing the remainder of its shares.
Online classifieds operator 58 has revealed it sold $713m of its shares in automotive e-commerce platform Chehaoduo to an investor likely to be SoftBank Vision Fund, which invested $1.5bn in Chehaoduo last week.
China-based Ruhnn is three years old and pursuing a very ‘now’ business model, operating a network of social media influencers that can be hired for promotions or marketing, and has filed to raise up to $200m in an IPO in the US.
Data management platform developer DataStax has hired underwriters to work on its own IPO, according to Reuters, and is seeking a $1bn valuation.
Precision BioSciences, a US-based genomic medicine spinout of Duke University, has filed to raise up to $100m in an initial public offering.